Your path to
permanent
residency
begins here.
Global City Regional Center helps qualified investors and their families pursue U.S. permanent residency through the EB-5 Immigrant Investor Program — backed by real projects, real job creation, and institutional credibility.
A trusted
partner in EB-5 investment.
Global City Regional Center is a USCIS-approved Regional Center designated to raise, invest, and manage funds through the EB-5 Immigrant Investor Program — fostering economic growth in the greater Philadelphia region since 2013.
USCIS Designated
Officially approved by USCIS since December 4, 2013, ensuring compliance and credibility for every investor we partner with.
Real Estate & Life Sciences
A unique dual focus - (a) real estate development fund; and (b) biopharma and life sciences investment fund - diversification across two resilient sectors.
Community Driven
Partners with established Community Development Corporations such as Philadelphia Chinatown Development Corporation (PCDC) and African Cultural Alliance of North America (ACANA); affiliated with JNA Capital.
Total project value across active EB-5 raises
Direct & indirect employment generated
Track record across every active investor petition
USCIS-designated since December 4, 2013
Confidence
in every step.
We combine government approval, strategic partnerships, and deep immigration expertise to guide your EB-5 journey from initial assessment through unconditional residency.
Proven track record
USCIS-designated with transparent compliance and an institutional reporting cadence across every active investor petition.
International reach
Distinguished advisory board with global diplomatic and business connections across Asia, the Middle East, and Latin America.
Strategic investments
Projects selected for strong job creation, government grants and economic impact, engineered to significantly exceed the 10-job minimum requirement.
Local expertise
Deep roots in the Philadelphia metropolitan area and Southern New Jersey with established community development relationships.
A direct path to
U.S. permanent
residency.
Created by Congress in 1990, the EB-5 program offers a direct path to U.S. permanent residency through qualified investments that create American jobs — no employer sponsorship required.
- Minimum investment · $800,000 in a Targeted Employment Area (TEA)
- Job creation · Each investment must create at least 10 full-time U.S. jobs
- Family inclusion · Spouse and unmarried children under 21 receive green cards
- No per-country quotas · Unlike employment-based categories, EB-5 is not constrained by country caps
Minimum investment in a USCIS-designated TEA.
Standard minimum outside a Targeted Employment Area.
Full-time U.S. positions per investor under EB-5 rules.
Spouse & unmarried children < 21 included.
Disciplined
offerings.
Verified impact.
A flagship $75 million, 20-story mixed-use development in Philadelphia's Chinatown North neighborhood — co-developed by PCDC and JNA Capital.
Eastern Tower
Crane Chinatown
A landmark mixed-use development at 10th & Vine Streets — co-developed by the Philadelphia Chinatown Development Corporation and JNA Capital. The project secured 16 EB-5 investors and $8.8M of EB-5 capital, with approval for up to 66 investors and $33M total raise.
Africa Center
Africatown · Philadelphia
The $24M Africa Center is the first phase of Dolakeh Square in Africatown — a community-led development serving the African diaspora across Southwest Philadelphia. Co-developed with the African Cultural Alliance of North America (ACANA), operating since 2000.
EB5 Life Sciences LP
Ocugen · Philadelphia
EB5 Life Sciences LP is GCRC's pioneering life sciences investment fund — the first in the EB5 industry to channel foreign investor capital into clinical-stage biopharmaceutical companies. The fund's flagship portfolio company, Ocugen, Inc. (Nasdaq: OCGN), develops cutting-edge gene therapies and biologics for sight-threatening eye diseases, with programs targeting retinal degeneration, macular degeneration, and other conditions with significant unmet need. A second portfolio company, Mainline Biosciences LLC, is advancing novel peptide compounds for cancer treatment, including selective CXCR4 antagonists targeting lung and breast cancer.
Your EB-
5 journey,
step by step.
From initial consultation through unconditional residency — a clear, structured pathway with experienced legal counsel and a USCIS-designated Regional Center at every stage.
Assess Suitability
Determine if the EB-5 program aligns with your immigration timeline and investment goals through a confidential eligibility assessment.
Due Diligence
Review offering documents, consult independent legal counsel, and evaluate the project, structure, and economic study.
File I-526E Petition
Submit your investor petition to USCIS and make your qualifying capital investment into the new commercial enterprise.
Receive Green Card
Obtain conditional residency, then file I-829 to remove conditions and secure permanent status for you and your family.
Backed by leaders in government, diplomacy, and community development — providing institutional credibility and a global network.
Latest
updates.
Stay informed with the latest announcements, project milestones, and industry insights from Global City Regional Center.
GCRC Announces Initial Close of EB5 Life Sciences LP
Global City Regional Center successfully completes the initial close for its pioneering biopharma and life sciences investment fund.
Africa Center Phase 1 Advances in Southwest Philadelphia
Development continues on the $24M community-led project in partnership with ACANA, anchoring the new Dolakeh Square.
Crane Chinatown Delivers on Job Creation Goals
The flagship 20-story mixed-use development reaches full operational status, significantly exceeding EB-5 job creation requirements.
Common
questions.
Quick answers to the most frequently asked questions about EB-5 — eligibility, timeline, and program mechanics.
Ready to begin your
EB-5 journey?
Schedule a confidential consultation to discuss your investment and immigration goals. No obligation — completely complimentary.
